Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
104 studies found for:    galantamine
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Galantamine
2 Completed
Has Results
Effect of Galantamine on Smoking Abstinence
Condition: Nicotine Addiction
Intervention: Drug: Galantamine ER
3 Completed Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder
Condition: Bipolar Disorder
Interventions: Drug: Galantamine-ER;   Drug: Galantamine placebo
4 Completed Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition
Condition: Fasting
Intervention: Drug: Reminyl
5 Completed Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition
Condition: Fed
Intervention: Drug: Reminyl
6 Active, not recruiting Effects of Galantamine on Cognition
Condition: Schizophrenia
Interventions: Drug: Galantamine;   Drug: Galantamine or Placebo
7 Completed
Has Results
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Galantamine
8 Terminated Efficacy of Galantamine to Treat Schizophrenia
Conditions: Schizophrenia;   Psychotic Disorder
Intervention: Drug: galantamine
9 Completed Characteristics of Treatment Responders to Galantamine
Condition: Dementia
Intervention: Drug: galantamine
10 Completed Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions
Condition: Healthy
Interventions: Drug: Galantamine 4 mg Tablet, single dose;   Drug: Reminyl 4 mg Tablet, single dose
11 Completed Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions
Condition: Healthy
Interventions: Drug: Galantamine 4 mg Tablet, single dose;   Drug: Reminyl 4 mg Tablet, single dose
12 Recruiting Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive Impairment
Conditions: Stroke;   Cognitive Impairment
Interventions: Drug: Galantamine;   Drug: placebo
13 Completed Galantamine Treatment for Nonfluent Aphasia in Stroke Patients
Conditions: Aphasia;   Stroke
Interventions: Drug: Galantamine;   Drug: Placebo pill
14 Completed Galantamine Effects on Nicotine Responses in Smokers
Conditions: Smoking;   Tobacco Withdrawal
Interventions: Drug: Galantamine;   Drug: IV Nicotine
15 Terminated Galantamine and Memantine for Cognitive Impairments in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Galantamine ER;   Drug: Memantine XR
16 Completed
Has Results
Galantamine Effects on Cognitive Function in Abstinent Cocaine Users
Condition: Cocaine Abuse
Interventions: Drug: Galantamine;   Drug: placebo
17 Terminated
Has Results
The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Galantamine
18 Completed Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse
Condition: Cocaine Dependence
Interventions: Drug: Galantamine;   Behavioral: Computer Assisted Cognitive Behavioral Therapy (CBT)
19 Completed
Has Results
The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning
Conditions: Major Depression;   Bipolar Depression;   Schizoaffective Disorder
Interventions: Drug: Razadyne;   Drug: Placebo
20 Completed Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
Condition: Alzheimer's Disease
Intervention: Drug: Galantamine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.